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ORGANIC VALVE DISEASES
Introduction
Doppler echocardiography has become the reference
method to describe valvular anatomy, establish the diagno-
sis of dysfunction and quantify precisely the mechanism
responsible for dysfunction by assessing the repercussions
on dimensions and function of the cardiac cavities and to
assess the resultant haemodynamic disturbances.
Quantification relies on the coherence of a number of para-
meters which when taken in isolation may be a source of
error. Assessment of regurgitation which is traditionally more
difficult than stenosis, has benefited from the use of the
proximal isovelocity surface area method (PISA). 
All the quantification methods, including assessment of a
stenosed orifice by the surgeon (which does not strictly
represent the functional in vivo orifice) have sources of
error, particularly in certain situations highlighting the
importance of comparing echocardiography results with cli-
nical findings; and in difficult cases (asymptomatic patients,
inconsistency between symptoms and the resting assess-
ment, low output etc.) it is useful to perform a dynamic test
(pharmacological or usually physical exercise). 
The indications for transoesophageal echocardiography
(TOE) have reduced in parallel to improvement in transtho-
racic imaging and are now reserved for well defined, speci-
fic situations. 
Finally, a range of investigations (coronary artery CT
scan or coronary angiography in particular), are still neces-
sary in a large number of patients prior to surgery.
Assessment of valve diseases: 
Methods of measurement
Orifice stenoses
Doppler echocardiography can be used to diagnose valvular
stenosis, to describe the extent of cusp damage (fibrosis,
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calcification), to assess the restriction (tethering?) of the
valve apparatus and to assess left ventricular function.
Aetiology and mechanism
Examination of the aortic valve is designed to assess the
level of valve calcification and to identify a bicuspid valve.
The diagnosis of a bicuspid aortic valve, although difficult
in diastole in the presence of a raphe or valve calcifications
is based on demonstrating 2 asymmetrical sigmoid cusps in
a short axis parasternal view.
Examination of the mitral valve must be exhaustive in
order to guide any possible therapeutic procedure. Diffe-
rent scores have been proposed, incorporating cusp thic-
kness and mobility, presence of calcifications, commissu-
ral areas and thickening of the subvalvular apparatus. In
particular, the importance of valvular calcifications and
the state of the subvalvular apparatus are anatomical fac-
tors that predict the success of percutaneous commissu-
rotomy.
Quantification
The quantification methods depend partly on the studied
orifice (tables 1-4):.Regardless of valve orifice, Doppler measurement of the
mean transvalvular pressure gradient correlates well
with the mean gradient found on catheterisation when
the measurements are performed simultaneously [1, 2].
It is always important to correctly align the transvalvular
flow and the ultrasound beam as a significant angle
between these two is liable to lead to gross under-esti-
mation of velocity and pressure gradient. This is a critical
point particularly for aortic stenoses — placing the probe
in different positions minimizes the angle between the
jet and the ultrasound beam. An adequate Doppler signal
is generally obtained from the apical position. However,
in some patients, despite an apical Doppler envelope of
acceptable quality, higher velocities may be are recor-
ded in the right parasternal or even suprasternal or
xiphoid views..Measurement of the functional surface area by the conti-
nuity equation is reliable for both mitral and aortic orifi-
ces [3, 4]. To optimise indications for treatment, parti-
cularly for the aortic orifice, body surface area needs to
be taken into account. This method requires coupling of
two-dimensional echocardiography and both Doppler
modes (pulsed and continuous). Apart from technical
problems related to errors in measuring the diameter of
the left ventricular outflow tract or incorrect positioning
of the pulsed Doppler sample, the method may be inap-
propriate in the presence of an accelerated flow in the
outflow tract, as well as in patients with mitral regurgi-
tation or atrial fibrillation with rapid ventricular res-
ponse. Although estimating valve surface area is less
dependent on haemodynamic conditions than estimation
of the gradient, some authors dispute its validity in
patients with low cardiac output [4 bis]. The measure-
ment of the radius of the Doppler colour convergence
zone [5] in 2D or TM mode, has been recently proposed
for the mitral orifice as alternative to the continuity
principle. However, this method is not frequently used in
routine practice..Measurement of the time required for the pressure across
the mitral valve during diastole to fall to one-half of its
initial value (pressure half time) can be use for the quan-
tification of mitral stenosis [6]. This is straightforward to
perform although its interpretation must take into
account technical causes of error (slope too short or non-
linear, atrial arrhythmias, etc.) and factors not related
to the mitral obstruction, primarily the features of left
ventricular filling or left atrial emptying. Concomitant
aortic regurgitation can also influence results..Direct measurement of the surface area of the stenosed
orifice by planimetry in two- or even three-dimensional
echocardiography is considered by many authors to be
the reference quantification method for mitral stenoses
[7]. It can also be used in selected cases for aortic steno-
ses, especially in multiplane transoesophageal echocar-
diography. Reliability depends on operator experience,
quality of instrument, observation conditions and ability
to determine the outline of the stenosed orifice (pro-
blems with irregular orifices and particularly with exten-
sive calcification etc.)..Other quantification indices (valve resistance, etc.) have
not been shown to be superior to the calculation of sur-
face area and are not used routinely.
Table 1 Aortic stenosis: obligatory parameters to record.
Parameters Threshold Comments Value
Maximal aortic velocity Severe AS >4 m/s Asymptomatic patients Prognostic value
Mean LV-Aorta gradient 
(rest)
Severe AS: >40 mmHg (ACC/
AHA)
Severe AS: >50 mmHg (ESC; SFC )
Several views 
(right parasternal ++)
Depends on output. 
Risk of underestimation if 
all views are not analyzed.
Aortic surface area 
continuity equation 
Severe AS <1 cm2 
(ACC/AHA, ESC)
Severe AS <0.5 cm2/m2 BSA (SFC)
Severe AS <0.6 cm2/m2 BSA
(ACC/AHA, ESC)
BSA indexation debatable: of 
use for extreme body mor-
photypes 
Less dependent on output. 
Invalid in outflow tract 
obstruction 
AS: aortic stenosis; BSA: body surface area; LV: left ventricle
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Table 2 Aortic stenosis: optional parameters.
Parameters Threshold Comments Value 
Exercise  Mean gradient >18 mmHg Asymptomatic patients Prognostic value to be 
confirmed (only 1 study) 
Low dose dobutamine Mean gradient >30 mmHg
Surface area <1.2 cm2
Patients with calcified 
valve, LVEF <40% and 
mean basal gradient 
LV- aorta <30 mmHg
Diagnostic and prognostic 
value
Surface area by planimetry Severe AS <1 cm2 (ACC/AHA, ESC)
Severe AS <0.5 cm2/m2 BSA 
(SFC)
Severe AS <0.6 cm2/m2 BSA 
(ACC/AHA, ESC)
Transthoracic or 
transoesophageal view
Limited to moderately 
calcified orifices when 
continuity equation invalid
Patency index Severe AS <25% Simple Relatively non-specific 
Valve resistance Severe AS >300 dynes.s.cm-5 Poor
LVEF: left ventricular ejection fraction; AS: aortic stenosis; BSA: body surface area; LV: left ventricle
Table 3 Mitral stenosis: obligatory parameters to record.
Parameters Threshold Comment Value
Mean LA-LV gradient 
(mmHg) (rest)
Moderate MS: 
<5 mmHg
Severe MS: 
>10 mmHg
Calculate mean measurements
(AF ++) 
Mediocre when performed alone 
(depends on output)
2D surface area Severe MS <1.5 cm2 
(<1 cm2/m2 BSA)
Measure the smaller orifice
(funnel tip) 
Anatomical surface area 
Gold standard
PHT surface area Severe MS <1.5 cm2 
(<1 cm2/m2 BSA)
Easy, quick Poor when performed alone 
Multiple causes of error
2D: two-dimensional; AF: atrial fibrillation; LA: left atrium; PHT: pressure half time; MS: mitral stenosis; LV: left ventricle
[the mean mitral gradient is only an argument supporting the degree of stenosis but cannot be a unique quantification factor]
Table 4 Mitral stenosis: optional parameters to record.
Parameters Threshold Comment Value
Mean LA-LV gradient on 
exercise
>15 mmHg Difficult if rapid heart rate Useful when basal evaluation difficult. 
Threshold value poorly documented 
prognostically
Systolic PAP on exercise >60 mmHg Threshold value poorly documented 
prognostically 
Continuity surface area Severe MS <1.5 cm2 
(<1 cm2/m2 BSA)
Pulmonary view rarely used 
Functional surface 
< anatomical surface area
Many causes of error 
3D surface area Severe MS <1.5 cm2
(<1 cm2/m2 BSA)
Appears to be more 
reproducible than 2D with 
inexperienced observers
Same limitations as 2D (echogenicity)
Specific equipment
PISA method (M-mode 
or 2D)
Severe MS <1.5 cm2 
(<1 cm2/m2 BSA)
Angle generally between 
100° and 130° 
Precise angle determination aleatory
PAP: pulmonary artery pressure; 2D: two-dimensional; 3D: three-dimensional; LA: left atrium; MS: mitral stenosis; LV: left ventricle
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Valve regurgitation
Doppler echocardiography provides a positive diagnosis of
valve regurgitation regardless of site, with a sensitivity and
specificity of close to 100%. It describes the aetiology,
mechanism [8] and severity of valve regurgitation [9].
Aetiology and mechanism
As regard to the aortic valve, echocardiography provides
morphological information on the number of valves and
valve texture, describes the size of the aortic annulus and
detects lesions susceptible to change the surgical strategy
or complicate surgery (dilatation of the ascending aorta,
annulus calcifications extending towards the aorto-mitral
trigone etc.).
At the mitral level, the functional classification proposed
by Carpentier is widely used: (type 1: normal valve move-
ments; type 2: valve prolapse; type 3: restricted valve
movements). In patients with prolapse, a segmental analy-
sis must also be performed. This analysis provides informa-
tion on the 8 segments of the mitral valve: 2 commissures,
3 segments for the posterior valve (P1, P2, P3) and 3 for the
anterior valve (A1, A2, A3). The use of such common classi-
fications improves the collaboration between cardiologist
and surgeon and clarifies the indications for treatment as
regard to the type of surgery considered, i.e. mitral valvu-
loplasty or valve replacement.
 At a tricuspid level, Doppler echocardiography can
detect large functional regurgitations with repercussion on
the right cavities which can be surgically resolved simulta-
neously with left heart lesions. It also describes the mecha-
nisms of rare organic valve damage (table 5).
Quantification
As for stenoses, quantification of regurgitations [9] is based
on a comparison of all the direct and indirect criteria [10-15]
reviewed below (tables 6-11). Indirect criteria are represen-
ted by the consequences of the regurgitation on the cardiac
cavities reflecting both the importance of the regurgitated
volume and the chronicity of the valvular lesion, but also by
haemodynamic repercussions (left ventricular filling pressu-
res, pulmonary artery pressure) The mechanism of the regur-
gitation is sometimes helpful for quantifying the severity
(severe valve damage, ruptures of the mitral valve papillary
muscle or cordae, and aortic sigmoid eversion are generally
associated with major regurgitations). Direct criteria are
recorded by Doppler. The study of the jet extension by
colour Doppler is a source of errors and has now become
obsolete. Semi-quantitative and quantitative methods are
widely used. Examining the proximal isovelocity surface area
offers major advantages as it provides an estimation of the
effective regurgitant orifice and the regurgitated volume
(speed, simplicity, validity in the presence of associated
valve disease or arrhythmias). However, methodological
limitations (particularly interaction with adjacent structu-
res) must not be underestimated. Overall, the number and
complementarity of available indices make ultrasound the
reference quantification method in routine practice. 
In clinical practice, the investigation always begins with
two-dimensional echocardiography which can suggest from
the outset severe regurgitation in the presence of a major
defect of valve closure or conversely, minor regurgitation
when the valve anatomy is normal. This is followed by a
careful assessment of the regurgitant jet by colour Doppler,
increasing the section planes. This allows a rapid diagnosis
of minimal regurgitation. Further quantification is gene-
rally not needed in these minimal regurgitations. In other
cases a quantitative methods are required. Analysis of the
proximal isovelocity surface area is the preferred method.
Results are then compared with semi-quantitative parame-
ters. The repercussion on the cardiac cavities and pulmo-
nary artery pressure are examined. In difficult cases tran-
soesophageal echocardiography is performed although
transthoracic approach is usually sufficient. 
Table 5 Doppler parameters used to quantify tricuspid regurgitation: threshold values.
Parameters Mild tricuspid regurgitation Severe tricuspid regurgitation 
Semi-quantitative
. vena contracta diameter
. systolic reversal of SHVF
 
absent
>7 mm
present
Quantitative
. effective regurgitant orifice area incompetence <20 mm2 >40 mm2
SHVF: suprahepatic venous flow
Table 6 Aortic regurgitation: obligatory parameters to record.
Parameters Comment Value
Pressure half Time Apical view usually
Right parasternal view (Pedoff) 
in some cases of prolapse 
Reflects LVEDP: 
Poor specificity for regurgitant volume 
Index of haemodynamic tolerance
Isthmus speed Minimum wall filter Good in adults 
VC Diameter TTE or TOE Good for central jets 
ERO and RV (PISA) Apical or parasternal view 
(prolapse ++)
Inferior compared with mitral regurgitation  (technical 
difficulties for radius determination).
+ Systematic left ventricular diameters
ERO: effective regurgitant orifice area; PISA: proximal isovelocity surface area; LVEDP: left ventricular end-diastolic pressure; 
SRO: surface area of regurgitant orifice; VC: vena contracta; RV: regurgitant volume
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Table 7 Aortic regurgitation: optional parameters to record.
Parameters Comment
Regurgitant fraction Long, tedious
Causes of error (mitral flow rate ++)
Aortic output Limited in LV dysfunction LV, AF…
AF: atrial fibrillation; LV: left ventricular
Table 8 Doppler parameters used to quantify aortic regurgitation: threshold values.
Parameters Moderate aortic regurgitation Severe aortic regurgitation 
Semi-quantitative 
. vena contracta diameter 
. aortic isthmus end-diastolic velocity 
. aortic output 
. pressure half time
<3 mm
absent or <10 cm/s
<6 L/min
>500 ms
>6 mm
>20 cm/s
>10 L/min
<300 ms
Quantitative
. effective regurgitant orifice area
. regurgitated volume/beat 
. regurgitation fraction 
<10 mm2
<30 ml
<30%
>30 mm2
>60 ml
>50%
Table 9 Mitral regurgitation: obligatory parameters to record.
Parameters Comment Value
ERO and RV (PISA) Limits: 
Multiple jets (Barlow)
Confined jets (commissural prolapse)
Current gold standard 
Probably overestimates regurgitations in MV 
prolapse 
Independent of load conditions 
Vena contracta diameter Preferably left parasternal view 
Use of zoom
limitations (echogenicity, multiple jets, 
eccentric jets)
+ indirect criteria systematically (cardiac cavities, pulmonary pressures, etc.) 
ERO: effective regurgitant orifice area; PISA: proximal isovelocity surface area; RV: regurgitated volume.
Table 10 Mitral regurgitation: optional parameters to record.
Parameters Comment Value
Regurgitant fraction Volume ejected at aortic annulus 
Total volume in 2D echo (Simpson)
Longer and more complex than PISA
Useful when PISA invalid or equivocal
Mitral VTI/Aortic VTI Simpler than calculating regurgitation fraction Limitations (associated valve disease, atrial 
fibrillation…)
VTI: velocity time integral; PISA: proximal isovelocity surface area
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Follow-up of organic left heart valve disease:
transthoracic Doppler echocardiography
The surgical indications, which largely depend on the echo-
cardiographical findings, are described in the recently
published recommendations from the valve group of the
Société Française de Cardiologie (SFC) [16], the European
Society of Cardiology (ESC) [17], and the American Heart Asso-
ciation/American College of Cardiology (AHA/ACC) [17 bis].
Aortic valve diseases
Moderate valve disease with no repercussions on the car-
diac cavities or left ventricular function, which do not pro-
duce symptoms and are clinically stable do not require
close regular monitoring. In other cases the methods and
frequency of Doppler echocardiography monitoring depend
on the valve disease in question.
Aortic stenosis
The natural history of degenerative aortic stenosis is relati-
vely well known: the aortic surface area has been shown to
fall by an average of 0.1 to 0.2 cm2 per year, although
considerable inter-individual differences exist. Asymptomatic
aortic stenosis has a good prognosis with a very low risk of sud-
den death [17, 18]. Different predictors of poor outcome in
asymptomatic patients have been identified: a peak aortic jet
velocity >4m/s, rapid increase in velocity >0.3 m/s per year,
the presence of extensive valve calcifications and finally an
abnormal response to exercise testing [16-19]. There are few
data suggesting the prognostic value of exercise echocardio-
graphy and its precise role remains to be established. The pro-
gnostic value of severe left ventricular hypertrophy (wall thic-
kness >15 mm) or a very high mean gradient (>75 mmHg) is
still subject of debate. Echocardiography has become the
standard method for assessing the severity of aortic stenosis.
The two main criteria in favor of severe aortic stenosis are a
mean gradient >50 mmHg, and an aortic valve area <1 cm2 (or
indexed aortic valve area <0.6 or 0.5 cm2/m2 in patients with
either unusually small or large body surface areas). It should
be emphasized that all of these measurements have potential
inaccuracies and must be considered in combination with flow
rate, ventricular function and functional status for clinical
decision making [16]. Annual Doppler echocardiography helps
to distinguish rapid progressors (reduction in aortic surface
area of more than 0.1 cm2/year) from patients in whom the
stenosis progresses slowly (reduction in aortic surface area of
less than 0.1 cm2/year). It is also used to monitor patients
with well tolerated severe aortic stenosis.
Aortic regurgitation
The indication for surgery in patients with severe aortic
regurgitation is undisputed clear in the presence of
symptoms due to the regurgitated volume and its haemo-
dynamic repercussions [16, 17]. The risks of surgery and
of prosthetic valve complications in asymptomatic
Table 11 Doppler parameters used to quantify organic, non-ischaemic mitral regurgitation: threshold values.
Parameters Mild mitral regurgitation Severe mitral regurgitation
Semi-quantitative
. vena contracta diameter
. Mitral VTI/Aortic VTI
. Pan- or mid-systolic reversal of PVF 
<3 mm
<1
absent
>7 mm
>1.4
present
Quantitative
. effective regurgitant orifice area
. regurgitant volume/beat
. regurgitation fraction
<20 mm2
<30 ml
<30%
>40 mm2
>60 ml
>50%
VTI: velocity time integral; PVF: pulmonary venous flow.
Indications for transthoracic Doppler echocardiography
in aortic stenosis
Classe I
— Initial work-up for clinically diagnosed aortic stenosis.
— Investigation of functional signs that might be due to 
aortic stenosis if the physical examination was not infor-
mative.
— Changes in functional signs or physical examination 
findings in a patient with known aortic stenosis.
— Annual or twice-yearly re-assessment of asymptoma-
tic, severe aortic stenosis.
— Annual re-assessment of moderate aortic stenosis with 
impaired left ventricular systolic function caused by 
some other aetiology.
— Twelve-month re-assessment of asymptomatic aortic 
stenosis initially judged as moderate. Later, annual 
check-ups in the event of rapid deterioration; every two 
or three years if deterioration is slower.
— Re-assessment of moderate-to-severe aortic stenosis 
before intermediate-to-high risk extracardiac surgery 
(see page 284) or before cardiovascular surgery if the 
last Doppler echocardiography was performed more than 
one year previously.
Classe II
— Re-assessment of moderate-to-severe aortic stenosis 
before intermediate-to-high risk extracardiac surgery 
(see page 284) or before cardiovascular surgery if the 
last Doppler echocardiography was performed less than 
one year previously.
Classe III
— Annual re-assessment of clinically stable, mild or 
slowly-deteriorating, asymptomatic aortic stenosis, 
without any significant impact on the heart cavities 
according to the initial examination.
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patients must be balanced against those due to the natu-
ral progression of the valve disease. It has been shown
that symptoms and/or left ventricular dysfunction deve-
lop at an annual rate of approximately 4% in asymptoma-
tic patients with aortic regurgitation [20]. Left ventricu-
lar dilatation (left ventricular end-diastolic diameter >70
mm and in particular, left ventricular end-systolic diameter
>50 mm or >25 mm/m2) and/or reduction in LV ejection
fraction (<50%) represent arguments for surgery in the
presence of severe aortic regurgitation [21]. Changes in
left ventricular function parameters have also a prognos-
tic role [20, 21] and some authors have proposed bian-
nual follow-up in patients with left ventricular end-systo-
lic diameters between 50 and 55 mm [20]. 
The natural history of aortic root aneurysm has been
mainly evaluated mostly in patients with Marfan’s syn-
drome or bicuspid aortic valve. The main predictive fac-
tors of aortic complications are the aortic diameter, the
rate of progression of aortic dilatation and a family history
of sudden death or aortic complication.
Mitral valve diseases
Mitral valve diseases must be investigated by Doppler echo-
cardiography in order to assess anatomical changes, seve-
rity, left ventricular repercussions (in mitral regurgitation)
and pulmonary pressures [9, 16].
Mitral stenosis 
Mitral stenosis is considered to be tight if the surface area
of the mitral valve is less than 1.5 cm2 (or 1 cm2/m2 body
surface area). 
Mitral stenosis usually progresses slowly, with a long asymp-
tomatic period. Progression of mitral stenosis is assessed by
measuring the mitral valve surface area and the variation of
the other parameters (gradient/pulmonary artery pressure/
left atrial diameter).
Percutaneous mitral dilatation
Baseline Doppler echocardiography must be performed
after percutaneous mitral dilatation, preferably under sta-
ble haemodynamic conditions, i.e. more than 48 hours after
the procedure. The frequency of subsequent investigations
is governed by the quality of the initial result.
Organic mitral regurgitation
The indication for surgery in patients with severe mitral
regurgitation is clear in the presence of symptoms due to the
regurgitated volume and its haemodynamic repercussions.
The approach varies in asymptomatic patients. The develop-
ment of left ventricular repercussions (left ventricular end-
systolic diameter of 45 mm or more, left ventricular ejection
fraction <60%) represents an indication for surgery. In asymp-
tomatic low-risk patients with severe regurgitation (regurgi-
tant orifice >40mm2 and/or regurgitated volume >60 ml/
Consensus indications for transthoracic Doppler echo-
cardiography in aortic regurgitation
Class I
— Initial assessment of clinically diagnosed aortic regur-
gitation.
— Changes in symptoms or clinical examination in 
patients previously diagnosed with known aortic regurgi-
tation.
— Annual or bi-annual (if rapid progression) evaluation of 
ascending aorta if >45 mm, in patients with aortic root 
aneurysm and bicuspid aortic valve
— Annual or bi-annual (according to severity and evolu-
tivity of left ventricular involvment) evaluation of 
severe asymptomatic aortic regurgitation medically fol-
lowed.
— Evaluation of a known moderate to severe AR before 
intermediate or high-risk extracardiac surgery (see page 
284) if the last Doppler echocardiography was performed 
more than one year previously.
— Reference examination within 3 months after aortic 
valve conservative surgery or Ross procedure.
Class II
— Annual assessment of moderately severe aortic regur-
gitation.
— Evaluation of a known moderate to severe AR before 
intermediate or high-risk extracardiac surgery (see page 
284) if the last Doppler echocardiography was performed 
less than one year previously.
Class III
— Annual re-assessment of minor aortic regurgitation 
with no left ventricular repercussions and stable clinical 
parameters.
Consensus indications for transthoracic Doppler echo-
cardiography in mitral stenosis
Class I
— Initial assessment of clinically diagnosed or suspected 
mitral stenosis.
— Changes in symptoms or clinical examination in patients 
with known mitral stenosis.
— Assessment of complications during evolution of mitral 
stenosis.
— Systematic reassessment of mitral stenosis, with a fre-
quency depending on the results of the initial evalua-
tion: yearly in severe mitral stenosis to several year 
intervals in moderate mitral stenosis
— Initial reassessment (first month) of mitral stenosis 
treated by percutaneous mitral commissurotomy (the 
frequency of subsequent follow-up is determined by the 
quality of the initial result).
— Re-assessment of moderately severe to severe mitral 
stenosis before intermediate or high risk extra-cardiac 
surgery (see page 284) or before cardiovascular surgery 
if the last Doppler echocardiography was performed 
more than one year previously.
Class II
— Re-assessment of moderately severe to severe mitral 
stenosis before intermediate or high risk extra-cardiac 
surgery (see page 284) or before cardiovascular surgery 
if the last Doppler echocardiography was performed less 
than one year previously.
Class III
— Annual re-assessment of clinically stable, non-tight 
mitral stenosis.
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beat) and favourable mitral anatomy, the current trend is to
operate early and perform valvuloplasty in order to preserve
left ventricular function and avoid left atrial dilatation [22].
If uncertainty about the feasibility of valvuloplasty exists, or
in the presence of co-morbidities regular follow-up is appro-
priate. Surgery becomes the rational choice at the occur-
rence of symptoms, left ventricular dysfunction, pulmonary
arterial hypertension or atrial fibrillation [22 bis]. In patients
with severe mitral regurgitation managed medically the main
risk is related to the insidious development of LV dysfunc-
tion. This justifies annual or bi-annual follow-up depending
on the initial findings.
Follow-up left heart valve
diseases: transoesophageal echocardiography 
.Transoesophageal echocardiography is particularly useful
for the diagnosis of complications of known valve disease.
Occasionally it helps determining the operative strategy in
patients in whom surgery is indicated. Transoesophageal
echocardiography is recommended in patients with a his-
tory of embolic events or in those in whom left atrial
thrombosis has to be excluded before cardioversion or
percutaneous mitral dilatation. The close relationship
between the oesophagus and the left atrium [23] and the
poor sensitivity of transthoracic echocardiography to
detect left atrial thromboses make transoesophageal
echocardiography a valuable procedure for assessing car-
diac thrombosis. Transoesophageal echocardiography is
also frequently used in patients with suspected endocardi-
tis, aortic wall complications or as an adjunct for exami-
ning the ascending aorta, particularly in bicuspid aortic
valve before surgery. Patients with severe mitral regurgi-
tation in whom the feasibility of conservative surgery
remains unclear after transthoracic echocardiography may
also benefit from the transesophageal approach. 
In aortic stenosis, the technique may be used for the
planimetry of the aortic orifice [24] in a minority of
patients in whom the transthoracic Doppler echocardiogra-
phy quantification provided inconsistent results (poor
observation conditions, flow acceleration in the outflow
tract etc.) and occasionally in selected patients with athe-
roma of the aortic arch at risk of complications at cathete-
risation or cardiac surgery. Transoesophageal echocardio-
graphy must be avoided in highly symptomatic tight aortic
stenosis. The preferred indications for transoesophageal
echocardiography in aortic regurgitation are suspected
endocarditis and suspected aortic wall complication, parti-
cularly in dystrophic aortic regurgitation. The method is
also recommended for the assessment of the regurgitation
mechanism when transthoracic observation conditions do
not permit definitive conclusions. 
Follow-up of organic left heart valve diseases:
transoesophageal echocardiography 
Several publications analyze the haemodynamic behaviour of
different left heart valve diseases during pharmacological or
physical stress [25-27]. In general terms, Doppler stress echo-
Consensus indications for transthoracic Doppler echo-
cardiography in organic mitral regurgitation
Class I
— Initial assessment of clinically diagnosed or suspected 
mitral regurgitation.
— Change in symptoms or clinical examination in 
patients with previously diagnosed mitral regurgi-
tation.
— Bi-annual or annual follow-up (depending on the seve-
rity and progression of the repercussions on left ventri-
cular function, left atrium and pulmonary artery 
pressure) for severe asymptomatic mitral regurgitation
— Baseline assessment during the 3 months following 
mitral valvuloplasty.
— Re-assessment of severe or moderately severe mitral 
regurgitation before intermediate or high risk extra-
cardiac surgery (see page 284) or before cardiovascular 
surgery if the last Doppler echocardiography was perfor-
med more than one year previously.
Class II
— Annual assessment of moderately severe mitral regur-
gitation without repercussions on cavities or left ventri-
cular function on the initial investigation with clinically 
stable parameters.
— Re-assessment of severe or moderately severe mitral 
regurgitation before intermediate or high risk extra-car-
diac surgery (see page 284) or before cardiovascular sur-
gery if the last Doppler echocardiography was less than 
one year previously. 
— Re-assessment of minor mitral regurgitation with val-
vular abnormalities and no repercussions on the cavities 
or left ventricular function on the initial examination, 
with stable clinical parameters, every 4 to 5 years.
Class III
— Annual re-assessment of moderate mitral regurgitation 
with no repercussions on the cavities or left ventricular 
function on the initial assessment, with stable clinical 
parameters.
Consensus indications for transoesophageal echocardio-
graphy in mitral stenosis
Class I
— Severe mitral stenosis when percutaneous dilatation is 
being considered (minimising the time between TOE and 
dilatation).
— Mitral stenosis complicated by an embolic event.
— Atrial dysrhythmias when cardioversion is being consi-
dered in a non-anticoagulated or poorly anticoagulated 
patient.
Class II
— Before intermediate or high risk extra-cardiac surgery 
(see page 284) or major cardiovascular surgery. 
— Atrial dysrhythmias when cardioversion is being consi-
dered in a well anticoagulated patient.
Class III
— Annual re-assessment of a mild mitral stenosis.
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cardiography can provide additional information to the base-
line assessment of valve diseases and refines indications for
treatment, particularly in asymptomatic patients or if symp-
toms are inconsistent with the baseline assessment. This
investigation is particularly useful when the “dynamic” nature
of the valve disease needs to be demonstrated (for example,
functional mitral regurgitation in heart failure). One specific
situation is aortic stenosis with severe left ventricular systolic
dysfunction associated with low output and a small gradient
(<30 mmHg). The haemodynamic response to dobutamine has
diagnostic value distinguishing significant stenoses from
moderate stenoses associated with independent left ventricu-
lar dysfunction but also prognostic value(assessment of the LV
contractile reserve) [26, 27].
Infective endocarditis
In infective endocarditis, an early diagnosis is essential.
Doppler echocardiography is currently the investigation
with the best performance in visualising vegetations and/or
assess valve dysfunction due to the endocarditis.
Consensus indications for transoesophageal echocardio-
graphy in organic mitral regurgitation
Class I
— Mechanism and quantification of mitral regurgitation 
inadequately assessed by transthoracic Doppler echocar-
diography.
— Mechanism and quantification of mitral regurgitation 
when transthoracic Doppler echocardiography and clini-
cal assessment produce inconsistent results.
— Development of a clinical event (suspected endocardi-
tis, embolic event, etc.). 
— Atrial dysrhythmias when cardioversion is being consi-
dered in a non-anticoagulated or poorly anticoagulated 
patient.
— Per-operative assessment of mitral regurgitation in 
mitral valvuloplasty.
Class II 
— Assessment of incompetent mitral valve before surgi-
cal correction.
— Assessment of the mechanism of moderate mitral 
regurgitation.
— Atrial dysrhythmias when cardioversion is being consi-
dered in a well anticoagulated patient.
Class III
— Moderate mitral regurgitation with no symptoms or 
repercussion on the cavities or left ventricular function 
on transthoracic Doppler echocardiography.
Consensus indications for transoesophageal echocardio-
graphy in aortic stenosis
Class I
— Suspected or overt infective endocarditis.
Class II
— Technical inability to correctly assess the severity 
extent of aortic stenosis by transthoracic Doppler echo-
cardiography.
— Investigation for associated lesions (thoracic aorta, other 
valve lesions, etc.) before aortic valve replacement.
Class III
— Initial assessment of aortic stenosis that was comple-
tely assessed by transthoracic Doppler echocardiography.
Consensus indications for transoesophageal echocardio-
graphy in aortic regurgitation
Class I
— Suspected aortic dissection in the presence of a dila-
ted and / or dystrophic aorta.
— Suspected or overt infective endocarditis.
— Mechanism and quantification of aortic regurgitation 
inadequately assessed by transthoracic Doppler echocar-
diography.
— Mechanism and quantification of aortic regurgitation 
when transthoracic Doppler echocardiography and clini-
cal assessment produce inconsistent results.
— Pre-operative assessment of annuloaortic ectasia when 
transthoracic Doppler echocardiography is inadequate. 
Class II
— Large volume aortic regurgitation with poor observation 
conditions by transthoracic Doppler echocardiography.
— Follow-up of progression of annuloaortic ectasia.
Class III
— Assessment of moderate aortic regurgitation with no 
symptoms or repercussion on the cavities or left ventricu-
lar function on transthoracic Doppler echocardiography.
Consensus indications for stress echocardiography in
organic left heart valve diseases 
Class I
— Low dose dobutamine Doppler echocardiography in 
aortic stenosis with low output (and small transvalvular 
gradient <30 mm Hg with left ventricular dysfunction)
— Exercise Doppler echocardiography to assess the tole-
rance of mitral stenosis and its repercussions on pulmo-
nary pressure when symptoms are difficult to assess or 
do not appear to be explained by the valve disease.
Class II
— Exercise Doppler echocardiography to assess the tole-
rance of organic mitral regurgitation, its severity and its 
repercussions on pulmonary pressure when symptoms 
are difficult to assess or do not appear to be explained 
by the valve disease.
Class III
— Exercise or Dobutamine Doppler echocardiography for 
routine assessment of organic mitral or aortic valve 
disease.
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Endocarditis on native valves 
The diagnostic criteria for infective endocarditis have recently
been modified [28] and Doppler echocardiography findings
have been included among in the major criteria (vegetations,
abscess, valve perforation, detachment of prosthesis, recent
regurgitation). The use of the new criteria improves the accu-
racy of the diagnosis of endocarditis [29]. The sensitivity of
transthoracic Doppler echocardiography to detect vegetations
is 50 to 60%. Transoesophageal echocardiography has
increased sensitivity (90 to 95%). When used together, the
specificity of these techniques is close to 100% [30].
Endocarditis on prosthetic valves
The incidence of endocarditis on prosthetic valves is 0.3 to
1.2%/patient year. Its’ complications carry a high mortality
[30 to 80% in early endocarditis; 20 to 40% in late forms [31-
32]], and are similar for mechanical prostheses and biopros-
theses.
Early diagnosis is essential. Doppler echocardiography is
currently the best investigation to visualise and measure
the size of vegetations, [33] and/or assess prosthetic dys-
function due to the endocarditis.
The diagnosis of endocarditis solely by transthoracic Dop-
pler echocardiography is difficult (acoustic shadow of the
prosthetic material). This limitation is resolved in part by
transoesophageal echocardiography, with a good sensitivity
and diagnostic accuracy as reported in the literature [34,
35]. The use of bi-and multi-plane probes undoubtedly
improves the sensitivity of the investigation [36]. However,
normal transoesophageal echocardiography does not for-
mally exclude the diagnosis of endocarditis on prosthesis
and the investigation should be repeated if suspicion per-
sists. The frequency of subsequent transoesophageal exa-
minations during follow-up is to be established considering
all clinical and laboratory parameters. Finally, transoeso-
phageal echocardiography is an essential investigation in
planning valve surgery and helps the choice of the best ope-
rative technique.
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VALVE PROSTHESES, 
VALVES REPAIR AND HOMOGRAFTS
When damage is incompatible with preserving the valve, the
treatment of the valve disease is replacement with a prosthe-
tic valve (approximately 9,000 cases per year in France). Two
main types of prostheses exist: mechanical prostheses (which
require long term anti-coagulation although their robustness
and longevity have been widely demonstrated [1, 2]) and bio-
logical prostheses (bioprostheses) which do not require any
specific treatment but have a shorter lifespan (average 10 to
15 years) because of risk of degeneration, which occurs faster
in people under 40 years [2, 3]. Aortic and mitral valve homo-
graft implantation is not widely used. In addition, whilst mitral
valve repair techniques are making rapid advances, aortic
valve repair techniques are not widely used in France.
Normal valve prostheses, 
valve repair and homografts
These display no abnormal clinical or radiological signs of dys-
function.
Initial assessment (2 or 3 months post-operatively)
Prosthetic valves
Each type of prosthesis has specific characteristics, represen-
ting a true echocardiographic and Doppler signature, which
depend on their haemodynamic profile, position and size. This
identity card is essential for patient follow-up.
